FDAnews
www.fdanews.com/articles/102491-bd-announces-ce-marking-of-rapid-superbug-test

BD Announces CE Marking of Rapid Superbug Test

December 20, 2007

BD Diagnostics, a segment of Becton Dickinson, launched its GeneOhm StaphSR assay for nasal and wound specimens in Europe after receiving a CE Marking for the product.

This is the first assay for the rapid and simultaneous identification and differentiation of Staphylococcus aureus (SA) and methicillin-resistant Staphylococcus aureus (MRSA) directly from nasal and wound specimens, the company said.

The assay is pending FDA clearance for various specimen types. The company said it also is developing rapid molecular tests for the detection of two other organisms that cause severe healthcare-associated infections.